BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24675483)

  • 1. Shortcomings in bladder cancer etiology research and a model for its prevention.
    Radosavljevic V; Belojevic G
    Tumori; 2014; 100(1):1-8. PubMed ID: 24675483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary prevention of bladder cancer. What's new?].
    Altwein JE
    Urologe A; 2007 Jun; 46(6):616-21. PubMed ID: 17464497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, Screening, and Prevention of Bladder Cancer.
    Lobo N; Afferi L; Moschini M; Mostafid H; Porten S; Psutka SP; Gupta S; Smith AB; Williams SB; Lotan Y
    Eur Urol Oncol; 2022 Dec; 5(6):628-639. PubMed ID: 36333236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
    Huber S; Schwentner C; Taeger D; Pesch B; Nasterlack M; Leng G; Mayer T; Gawrych K; Bonberg N; Pelster M; Johnen G; Bontrup H; Wellhäusser H; Bierfreund HG; Wiens C; Bayer C; Eberle F; Scheuermann B; Kluckert M; Feil G; Brüning T; Stenzl A;
    BJU Int; 2012 Sep; 110(5):699-708. PubMed ID: 22313585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case-control studies.
    Sciannameo V; Carta A; d'Errico A; Giraudo MT; Fasanelli F; Arici C; Maule M; Carnà P; Destefanis P; Rolle L; Gontero P; Casetta G; Zitella A; Cucchiarale G; Vineis P; Porru S; Sacerdote C; Ricceri F
    Int Arch Occup Environ Health; 2019 Apr; 92(3):347-359. PubMed ID: 30506367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do I tell my patients about drinking water and the risk of bladder cancer?
    Moyad MA
    Urol Nurs; 2003 Oct; 23(5):371-7. PubMed ID: 14621363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).
    Roobol MJ; Bangma CH; el Bouazzaoui S; Franken-Raab CG; Zwarthoff EC
    Urol Oncol; 2010; 28(6):686-90. PubMed ID: 21062653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental non-occupational risk factors associated with bladder cancer.
    Ferrís J; Berbel O; Alonso-López J; Garcia J; Ortega JA
    Actas Urol Esp; 2013 Oct; 37(9):579-86. PubMed ID: 23618510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for bladder cancer in high-risk groups: delineation of the problem.
    Schulte PA
    J Occup Med; 1990 Sep; 32(9):789-92. PubMed ID: 2074499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer: approaches to prevention and control.
    Koroltchouk V; Stanley K; Stjernswärd J; Mott K
    Bull World Health Organ; 1987; 65(4):513-20. PubMed ID: 3121200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer: a selected review of the epidemiological literature.
    Pirastu R; Iavarone I; Comba P
    Ann Ist Super Sanita; 1996; 32(1):3-20. PubMed ID: 8967723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries.
    Lakkis NA; Adib SM; Hamadeh GN; El-Jarrah RT; Osman MH
    Cancer Control; 2018; 25(1):1073274818789359. PubMed ID: 30027755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary factors associated with bladder cancer.
    Piyathilake C
    Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S14-25. PubMed ID: 27326403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of a screening method for occupational bladder cancer].
    Borchini R; Bonzini M; Veronesi G; Fava C; Carenzi MC; Mombelli S; Marconi A; Bono AV; Ferrario MM
    Med Lav; 2009; 100(6):438-47. PubMed ID: 20359136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer risk from occupational and environmental exposures.
    Kiriluk KJ; Prasad SM; Patel AR; Steinberg GD; Smith ND
    Urol Oncol; 2012; 30(2):199-211. PubMed ID: 22385990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.
    Clin B; ; Pairon JC
    BMC Public Health; 2014 Nov; 14():1155. PubMed ID: 25377503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The causes of urinary bladder cancer and possibilities of prevention].
    Golka K; Rettenmeier AW; Goebell PJ
    Urologe A; 2006 Mar; 45(3):361-7; quiz 368. PubMed ID: 16514529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational exposure to urinary bladder carcinogens - risk factors, molecular mechanisms and biomarkers.
    Oţelea MR; Jinga V; Raşcu AŞC; Pleşea IE; Petrescu AN; Mitrache LE; Olteanu M; Bondari D; Raşcu A
    Rom J Morphol Embryol; 2018; 59(4):1021-1032. PubMed ID: 30845280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
    Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
    BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.